Rapid mass-screening diagnostic test for COVID-19
The COVID-19 crisis has challenged traditional timelines for everything from vaccine manufacture and clinical trials to diagnostics development. In a joint project from Stream Bio and MIP Diagnostics Ltd, a superior rapid diagnostic and associated mass screening test can be developed with an estimated timeline of just 11 weeks. It has the potential to reduce …
Rapid mass-screening diagnostic test for COVID-19 Read More »
